Background: Cancer diagnosis is related to poor short-term cognition, reflecting the condition, stress, and management. Less is known about long-term relationships between time since cancer diagnosis and cognition. We evaluated the association between recency of cancer diagnosis and cognition.

Method: The National Health and Nutrition Examination Survey is a nationally representative, cross-sectional survey of community-dwelling people in the United States. In 2011-2012 and 2013-2014, the study included questions on the timing of cancer diagnosis. Participants age ≥ 60 years completed the Digit Symbol Substitution Test and the Consortium to Establish a Registry for Alzheimer's Disease Total Learning Test and Recall Test. Our analytic sample included individuals age ≥ 60 years who reported a cancer diagnosis and completed all cognitive tests. We calculated z-scores for each cognitive test and a global score (sum across individual z-scores). We used linear regression to assess the relationship between time since cancer diagnosis (current -5 years, >5 years) and cognition. We estimated an age and sex-adjusted model and included potential confounders in a series of nested models, with each step adding: race and ethnicity, education level, marital status, and health insurance status. Analyses were weighted such that results represent the US community-dwelling population.

Result: The analysis sample included 477 participants who ever had a cancer diagnosis, excluding unknown and non-melanoma skin cancers, corresponding to an implied population of 9,027,595 (including 11% melanoma skin, 23% breast, 16% prostate) with a mean age of 71.2 years (SD = 6.6). A total of 31% of participants reported a cancer diagnosis within the past five years. Demographic characteristics were similar based on cancer diagnosis timing. Adjusting for age and sex, participants greater than five years from cancer diagnosis had a higher cognition level, compared to those with a cancer diagnosis within five years (coefficient = 0.22, 95% CI = 0.05, 0.39). Results were similar when adjusting for additional covariates.

Conclusion: Among older adults who ever had a cancer diagnosis, a diagnosis that occurred more than 5 years ago was related to better cognition. Future studies should investigate the roles of cancer site, treatments, and stage at diagnosis in this relationship.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.092394DOI Listing

Publication Analysis

Top Keywords

cancer diagnosis
48
diagnosis
14
cancer
13
years
9
time cancer
8
age ≥
8
≥ years
8
sample included
8
reported cancer
8
diagnosis years
8

Similar Publications

Nasopharyngeal carcinoma (NPC) is a prevalent malignancy in China, commonly associated with undifferentiated cell types and Epstein-Barr virus (EBV) infection. The presence of intense lymphocytic infiltration and elevated expression of programmed cell death ligand 1(PD-L1) in NPC highlights its potential for immunotherapy, yet current treatment outcomes remain suboptimal. In this review, we explore the tumor microenvironment of NPC to better understand the mechanisms of resistance to immunotherapy, evaluate current therapeutic strategies, and pinpoint emerging targets, such as tertiary lymphoid structures (TLSs), that could enhance treatment outcomes and prognostic accuracy.

View Article and Find Full Text PDF

Purpose: The prognosis of relapsed primary central nervous system lymphoma remains a concern. This study aimed to compare the effects of various patient- and disease-related factors on the prognosis of relapsed primary central nervous system lymphoma (PCNSL).

Methods: We retrospectively collected real-world data from eight Finnish hospitals on 198 patients diagnosed with PCNSL between 2003 and 2020.

View Article and Find Full Text PDF

Background: Up to 23% of breast cancer patients recurred within a decade after trastuzumab treatment. Conversely, one trial found that patients with low HER2 expression and metastatic breast cancer had a positive response to trastuzumab-deruxtecan (T-Dxd). This indicates that relying solely on HER2 as a single diagnostic marker to predict the efficacy of anti-HER2 drugs is insufficient.

View Article and Find Full Text PDF

Background: This study aims to quantify intratumoral heterogeneity (ITH) using preoperative CT image and evaluate its ability to predict pathological high-grade patterns, specifically micropapillary and/or solid components (MP/S), in patients diagnosed with clinical stage I solid lung adenocarcinoma (LADC).

Methods: In this retrospective study, we enrolled 457 patients who were postoperatively diagnosed with clinical stage I solid LADC from two medical centers, assigning them to either a training set (n = 304) or a test set (n = 153). Sub-regions within the tumor were identified using the K-means method.

View Article and Find Full Text PDF

Background: Pulmonary space-occupying lesions are typical chronic pulmonary diseases that contribute significantly to healthcare resource use and impose a large disease burden in China. A time-series ecological trend study was conducted to investigate the associations between environmental factors and hospitalizations for pulmonary space-occupying lesions in North of China from 2014 to 2022.

Methods: The DLNM was used to quantify the association of environmental factors with lung cancer admissions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!